Literature DB >> 21309084

Megakaryocyte lineage-specific class VI β-tubulin suppresses microtubule dynamics, fragments microtubules, and blocks cell division.

Hailing Yang1, Anutosh Ganguly, Shanghua Yin, Fernando Cabral.   

Abstract

Class VI β-tubulin (β6) is the most divergent tubulin produced in mammals and is found only in platelets and mature megakaryocytes. To determine how this unique tubulin isotype affects microtubule assembly and organization, we expressed the cDNA in tissue culture cells under the control of a tetracycline regulated promoter. The β6 coassembled with other endogenous β-tubulin isotypes into a normal microtubule array; but once the cells entered mitosis it caused extensive fragmentation of the microtubules, disrupted the formation of the spindle apparatus, and allowed entry into G1 phase without cytokinesis to produce large multinucleated cells. The microtubule fragments persisted into subsequent cell cycles and accumulated around the membrane in a marginal band-like appearance. The persistence of the fragments could be traced to a pronounced suppression of microtubule dynamic instability. Impairment of centrosomal nucleation also contributed to the loss of a normal microtubule cytoskeleton. Incorporation of β6 allowed microtubules to resist the effects of colcemid and maytansine, but not vinblastine or paclitaxel; however, cellular resistance to colcemid or maytansine did not occur because expression of β6 prevented cell division. The results indicate that many of the morphological features of megakaryocyte differentiation can be recapitulated in non-hematopoietic cells by β6 expression and they provide a mechanistic basis for understanding these changes.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21309084      PMCID: PMC3082363          DOI: 10.1002/cm.20503

Source DB:  PubMed          Journal:  Cytoskeleton (Hoboken)        ISSN: 1949-3592


  41 in total

Review 1.  Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics.

Authors:  K H Downing
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

2.  Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2.

Authors:  P Lecine; J E Italiano; S W Kim; J L Villeval; R A Shivdasani
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

3.  Paclitaxel-dependent cell lines reveal a novel drug activity.

Authors:  Anutosh Ganguly; Hailing Yang; Fernando Cabral
Journal:  Mol Cancer Ther       Date:  2010-10-26       Impact factor: 6.261

Review 4.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

5.  Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs.

Authors:  Hailing Yang; Anutosh Ganguly; Fernando Cabral
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

Review 6.  Post-translational modifications of microtubules.

Authors:  Dorota Wloga; Jacek Gaertig
Journal:  J Cell Sci       Date:  2010-10-15       Impact factor: 5.285

Review 7.  Tracking the ends: a dynamic protein network controls the fate of microtubule tips.

Authors:  Anna Akhmanova; Michel O Steinmetz
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03-05       Impact factor: 94.444

8.  Visualization of microtubule growth in living platelets reveals a dynamic marginal band with multiple microtubules.

Authors:  Sunita Patel-Hett; Jennifer L Richardson; Harald Schulze; Ksenija Drabek; Natasha A Isaac; Karin Hoffmeister; Ramesh A Shivdasani; J Chloë Bulinski; Niels Galjart; John H Hartwig; Joseph E Italiano
Journal:  Blood       Date:  2008-01-29       Impact factor: 22.113

9.  Structural basis for the regulation of tubulin by vinblastine.

Authors:  Benoît Gigant; Chunguang Wang; Raimond B G Ravelli; Fanny Roussi; Michel O Steinmetz; Patrick A Curmi; André Sobel; Marcel Knossow
Journal:  Nature       Date:  2005-05-26       Impact factor: 49.962

10.  A minor beta-tubulin essential for mammalian cell proliferation.

Authors:  Rajat Bhattacharya; Anthony Frankfurter; Fernando Cabral
Journal:  Cell Motil Cytoskeleton       Date:  2008-09
View more
  8 in total

1.  The arresting action of microtubules in cell motility.

Authors:  Anutosh Ganguly; Fernando Cabral
Journal:  Cell Cycle       Date:  2011-08-15       Impact factor: 4.534

Review 2.  New insights into mechanisms of resistance to microtubule inhibitors.

Authors:  Anutosh Ganguly; Fernando Cabral
Journal:  Biochim Biophys Acta       Date:  2011-06-29

Review 3.  Regulation of Tubulin Gene Expression: From Isotype Identity to Functional Specialization.

Authors:  Ivana Gasic
Journal:  Front Cell Dev Biol       Date:  2022-05-26

4.  Class III β-tubulin counteracts the ability of paclitaxel to inhibit cell migration.

Authors:  Anutosh Ganguly; Hailing Yang; Fernando Cabral
Journal:  Oncotarget       Date:  2011-05

5.  AP-1-mediated expression of brain-specific class IVa β-tubulin in P19 embryonal carcinoma cells.

Authors:  Yuka Maruyama; Kazuhiko Arahara; Emi Kinoshita; Katsuhiko Arai
Journal:  J Vet Med Sci       Date:  2014-09-26       Impact factor: 1.267

6.  Possible Roles of Specific Amino Acids in β-Tubulin Isotypes in the Growth and Maintenance of Neurons: Novel Insights From Cephalopod Mollusks.

Authors:  Richard F Ludueña
Journal:  Front Mol Neurosci       Date:  2022-04-14       Impact factor: 6.261

7.  Microtubule Hyperacetylation Enhances KL1-Dependent Micronucleation under a Tau Deficiency in Mammary Epithelial Cells.

Authors:  Haruka Sudo
Journal:  Int J Mol Sci       Date:  2018-08-23       Impact factor: 5.923

8.  Microtubule polyglutamylation and acetylation drive microtubule dynamics critical for platelet formation.

Authors:  Juliette van Dijk; Guillaume Bompard; Julien Cau; Shinji Kunishima; Gabriel Rabeharivelo; Julio Mateos-Langerak; Chantal Cazevieille; Patricia Cavelier; Brigitte Boizet-Bonhoure; Claude Delsert; Nathalie Morin
Journal:  BMC Biol       Date:  2018-10-18       Impact factor: 7.431

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.